According to Halozyme Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 135,284,000. At the end of 2022 the company had 135,284,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 0.13 B | -3.52% |
2021 | 0.14 B | 3.79% |
2020 | 0.13 B | -4.21% |
2019 | 0.14 B | -2.19% |
2018 | 0.14 B | 1.75% |
2017 | 0.14 B | 10.56% |
2016 | 0.12 B | 0.78% |
2015 | 0.12 B | 2.35% |
2014 | 0.12 B | 9.44% |
2013 | 0.11 B | 1.09% |
2012 | 0.11 B | 8.81% |
2011 | 0.10 B | 10.26% |
2010 | 93.62 M | 4.53% |
2009 | 89.57 M | 11.55% |
2008 | 80.29 M | 4.96% |
2007 | 76.5 M | 21.95% |
2006 | 62.73 M | 25.52% |
2005 | 49.97 M | 26.29% |
2004 | 39.57 M | 382.82% |
2003 | 8.19 M | 327.5% |
2002 | 1.91 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,634,300,000 | 1,847.24% | ๐บ๐ธ USA |
![]() Pfizer PFE | 5,634,000,000 | 4,064.57% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 950,182,000 | 602.36% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,508,000,000 | 1,753.88% | ๐ซ๐ท France |
![]() Baxter BAX | 504,000,000 | 272.55% | ๐บ๐ธ USA |
![]() MannKind Corp MNKD | 263,378,000 | 94.69% | ๐บ๐ธ USA |